Science 37 Holdings, Inc. (SNCE)
| Market Cap | 31.88M |
| Revenue (ttm) | 60.26M |
| Net Income (ttm) | -124.65M |
| Shares Out | 5.97M |
| EPS (ttm) | -21.20 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45,861 |
| Open | 5.30 |
| Previous Close | 5.27 |
| Day's Range | 5.07 - 5.85 |
| 52-Week Range | 3.73 - 13.80 |
| Beta | 0.49 |
| Analysts | Buy |
| Price Target | 20.00 (+274.53%) |
| Earnings Date | Nov 7, 2023 |
About SNCE
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support v... [Read more]
Financial Performance
In 2022, SNCE's revenue was $70.15 million, an increase of 17.70% compared to the previous year's $59.60 million. Losses were -$50.99 million, -45.95% less than in 2021.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for SNCE stock is "Buy" and the 12-month stock price forecast is $20.0.
News
Science 37 Receives Top Honors in Everest PEAK Matrix®
Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical Trials Science 37 emerges as the only clinical trial site to be recognized as a Leader in Dece...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under...
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37” or the “Company”), the clinical research industry-leading Metasite™, announced to...
Science 37 Reports Third Quarter 2023 Financial Results
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the q...
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial res...
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery Off...
Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Science 37 announced today that it has been recognized in the Gartner Hype Cycle for Life Science Clinical Development, 2023. As stated...
Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored wi...
Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upco...
Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards
RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ is proud to announce its nomination for the p...
Science 37 Reports Second Quarter 2023 Financial Results
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the q...
Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial re...
Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Acces...
Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"
Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation Science 37's unified platform that powers the Metasite receives award for...
Science 37 Reports First Quarter 2023 Financial Results
RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the qu...
Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot
Strategic partnership will leverage Science 37's leadership in remote and hybrid clinical research to enable expansive clinical trial access for oncology patients Strategic partnership will leverage S...
Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023
RESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial resu...
Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity
New role supports the Company's objective to lead the industry with faster, more inclusive clinical research New role supports the Company's objective to lead the industry with faster, more inclusive ...
Science 37 Adds New Head of Quality, Irena Lambridis
New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality
Science 37 to Host Business Update Call on April 12, 2023
RESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will host a business update conference call...
Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality
Centers of Excellence to strengthen and scale the company's Metasite offering and accelerate its path to profitability Centers of Excellence to strengthen and scale the company's Metasite offering and...
Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results
RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the ...
Science 37 to Present at the Cowen 43rd Annual Health Care Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcom...
Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial re...
Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under...